Previous close | 335.83 |
Open | 338.23 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 327.41 - 338.23 |
52-week range | 327.41 - 338.23 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 0.93 |
PE ratio (TTM) | 62.01 |
EPS (TTM) | 5.30 |
Earnings date | 27 Apr 2022 - 02 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Let's look at two top stocks that have performed worse than the broader market this year: DexCom (NASDAQ: DXCM) and Microsoft (NASDAQ: MSFT). Shares of medical devices specialist DexCom have dropped by 39% year to date. DexCom's own G6 CGM system continues to be highly successful.
SAN DIEGO, May 10, 2022--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:
With its stock down 23% over the past month, it is easy to disregard DexCom (NASDAQ:DXCM). However, stock prices are...